The Schall Law Probes Valneva Over Vaccine Safety Concerns.
Back in late February, concerns started swirling around Valneva SE (NASDAQ: VALN) after safety issues were linked to its chikungunya vaccine, IXCHIQ.
Now, The Schall Law Firm is taking a closer look. The firm is investigating whether Valneva may have misled investors or left out key details about the vaccine’s risks.
CDC Sounds the Alarm on IXCHIQ
On February 25, 2025, the Centers for Disease Control and Prevention (CDC) issued a notice saying it’s investigating five hospitalizations tied to Valneva’s vaccine. The reported cases involved people 65 and older who experienced cardiac or neurological complications shortly after getting the shot.
The news caught the attention of investors—and not in a good way. Over the course of a few trading sessions, Valneva’s ADR (American Depositary Receipt) shares dropped more than 13.5%.
The Schall Law Firm is asking whether Valneva left investors in the dark. Their investigation focuses on whether the company:
-
Made public statements that were incomplete or misleading, or
-
Failed to share known risks about the vaccine in time
If that’s the case, shareholders who took a hit could have legal grounds to seek compensation under federal securities laws.
Valneva SE is a specialty vaccine company headquartered in France, focused on developing and commercializing vaccines for infectious diseases with unmet medical needs. Its portfolio includes licensed vaccines like IXIARO® (Japanese encephalitis), DUKORAL® (cholera), and IXCHIQ® (chikungunya), along with R&D programs for Lyme disease, Zika, and Shigella.
What Investors Can Do Now
If you held Valneva shares and saw losses after the CDC’s announcement, you might have options. The Schall Law Firm is offering free consultations to help investors understand their rights and figure out whether joining a potential class action makes sense.
To speak with someone at the firm, you can reach out to attorney Brian Schall at:
-
📍 2049 Century Park East, Suite 2460, Los Angeles, CA 90067
-
📞 (310) 301-3335
The Schall Law Firm is a prominent national litigation firm dedicated to protecting the rights of investors. Specialising in shareholder rights, the firm advocates for individuals who have suffered financial losses due to corporate misconduct, securities fraud, and violations of federal laws. With years of experience, the Schall Law Firm is known for its aggressive representation in class action lawsuits and securities fraud claims. The firm is committed to achieving justice for its clients by holding companies accountable for misleading statements and unethical practices.
More Articles
